MRK Earnings Date & History
Merck & Co Inc (NEW YORK STOCK EXCHANGE, INC.) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 6:23 PM ET
Merck & Co Inc
Pharmaceuticals
- Next earnings date
- Thursday, October 29, 2026
- Reporting session
- Time TBD
- EPS estimate
- $2.25
- Revenue estimate
- $17.49B
MRK earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Tuesday, August 4, 2026 | Q2 2026 | $-0.27 | $-0.13 | +52.3% | $16.61B |
| Thursday, April 30, 2026 | Q1 2026 | $-1.52 | $-1.28 | +16.0% | $16.29B |
| Tuesday, February 3, 2026 | Q4 2025 | $2.03 | $2.09 | +3.0% | $16.40B |
| Thursday, October 30, 2025 | Q3 2025 | $2.37 | $2.68 | +13.1% | $17.28B |
| Tuesday, July 29, 2025 | Q2 2025 | $2.03 | $2.19 | +7.7% | $15.81B |
What the market is watching in MRK's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next MRK earnings date?
- Merck & Co Inc is scheduled to report on Thursday, October 29, 2026 (Time TBD). Dates can change until the company confirms them.
- Does MRK report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for MRK?
- Consensus EPS for the upcoming quarter is $2.25, on revenue of $17.49B.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
MRK earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.